Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenyong Yang

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Oncology|February 26, 2025
Advances in sodium-glucose transporter protein 2 inhibitors and tumorsJiaqi Wang, Wenyong Yang
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2020
CD4<sup>+</sup> T-Cell Differentiation In VitroWenyong Yang, Xueying Chen, Hongbo Hu
Journal of Pharmaceutical Analysis|June 12, 2025
Targeting tumor metabolism to augment CD8<sup>+</sup> T cell anti-tumor immunityHuan Liu, Wenyong Yang, Jingwen Jiang
Small (Weinheim an Der Bergstrasse, Germany)|December 10, 2023
Comment on "An Injectable Hydrogel to Modulate T Cells for Cancer Immunotherapy"Liangbin Lin, Sunfu Zhang, Wenyong Yang
Respiratory Medicine Case Reports|July 29, 2024
A case report of high-grade fetal lung adenocarcinoma with KRAS mutationWang Jiaqi, Zhao Shicai, Yu Bin, et al.
Drug Development Research|August 28, 2014
Redox regulation of cancer metastasis: molecular signaling and therapeutic opportunitiesWenyong Yang, Linzhi Zou, Canhua Huang, et al.
Frontiers in Immunology|October 29, 2020
To TRIM the Immunity: From Innate to Adaptive ImmunityWenyong Yang, Zhiwen Gu, Huiyuan Zhang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 20, 2024
Targeting CD8<sup>+</sup> T cells with natural products for tumor therapy: Revealing insights into the mechanismsYuke Wang, Yan Zeng, Wenyong Yang, et al.
Journal of Pharmaceutical Analysis|February 9, 2026
Targeted nano-drug delivery systems for tumor immunotherapyShan Lian, Wenyong Yang, Yan Zeng, et al.
Scientific Reports|February 2, 2024
Identification of EMT-associated prognostic features among grade II/III gliomasWenyong Yang, Liangbin Lin, Tianqi Lu, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|February 26, 2025
Advances in sodium-glucose transporter protein 2 inhibitors and tumorsJiaqi Wang, Wenyong Yang
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2020
CD4<sup>+</sup> T-Cell Differentiation In VitroWenyong Yang, Xueying Chen, Hongbo Hu
Journal of Pharmaceutical Analysis|June 12, 2025
Targeting tumor metabolism to augment CD8<sup>+</sup> T cell anti-tumor immunityHuan Liu, Wenyong Yang, Jingwen Jiang
Small (Weinheim an Der Bergstrasse, Germany)|December 10, 2023
Comment on "An Injectable Hydrogel to Modulate T Cells for Cancer Immunotherapy"Liangbin Lin, Sunfu Zhang, Wenyong Yang
Respiratory Medicine Case Reports|July 29, 2024
A case report of high-grade fetal lung adenocarcinoma with KRAS mutationWang Jiaqi, Zhao Shicai, Yu Bin, et al.
Drug Development Research|August 28, 2014
Redox regulation of cancer metastasis: molecular signaling and therapeutic opportunitiesWenyong Yang, Linzhi Zou, Canhua Huang, et al.
Frontiers in Immunology|October 29, 2020
To TRIM the Immunity: From Innate to Adaptive ImmunityWenyong Yang, Zhiwen Gu, Huiyuan Zhang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 20, 2024
Targeting CD8<sup>+</sup> T cells with natural products for tumor therapy: Revealing insights into the mechanismsYuke Wang, Yan Zeng, Wenyong Yang, et al.
Journal of Pharmaceutical Analysis|February 9, 2026
Targeted nano-drug delivery systems for tumor immunotherapyShan Lian, Wenyong Yang, Yan Zeng, et al.
Scientific Reports|February 2, 2024
Identification of EMT-associated prognostic features among grade II/III gliomasWenyong Yang, Liangbin Lin, Tianqi Lu, et al.
Pageof 3